ClinicalTrials.Veeva

Menu

The Validity and Reliability of the Turkish Version of TASC and the Relationship Between SMC and Motor Functions

G

Gazi University

Status

Completed

Conditions

Cerebral Palsy, Monoplegic
Cerebral Palsy, Spastic
Cerebral Palsy Spastic Diplegia
Cerebral Palsy
Cerebral Palsy Quadriplegic

Study type

Observational

Funder types

Other

Identifiers

NCT04231227
Upper Limb SMC in CP

Details and patient eligibility

About

Selective motor control (SMC) impairment in children with cerebral palsy (CP) includes movement patterns dominated by flexor or extensor synergy affecting functional movements. The research was designed to investigate the validity and the reliability of the Turkish version of the Test of Arm Selective Control (TASC) (which is improved to evaluate SMC in children with spastic CP) and in order to provide more understanding of the relationship between SMC and upper extremity and gross motor functions. The study included 21 hemiplegic, 11 diplegic and 4 quadriplegic children with CP whose ages are 4 to 18 years and Gross Motor Function Classification System (GMFCS) level changes from 1 to 4, and their parents. In order to evaluate the gross motor function of children, GMFCS and the ability to hold objects with their hands in daily activities were evaluated with Manual Ability Classification System (MACS). ABILHAND-Kids scale was applied to evaluate upper extremity performance. TASC scale was used to evaluate the upper extremity SMC of children.

Enrollment

36 patients

Sex

All

Ages

4 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • having a diagnosis of spastic CP
  • being able to understand the commands required for the test,
  • being between the ages of 3-18,
  • being GMFCS level I to IV.

Exclusion Criteria: • Having undergone orthopedic surgery or Botulinum Toxin A (BTX-A) within the last 6 months

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems